T he upside for Ranbaxy Laboratories [ Get Quote ] is likely to continue even as it loses its 180 days of marketing exclusivity for the Lipitor generic in the American market. While Teva recently withdrew plans to launch its generic version of Lipitor in the US, other companies such as Dr Reddy's Laboratories...
FULL ARTICLE AT India Abroad